CY1106019T1 - Θepαπευτικη αγωγη αντικαταστασεως των οιστρογονων - Google Patents

Θepαπευτικη αγωγη αντικαταστασεως των οιστρογονων

Info

Publication number
CY1106019T1
CY1106019T1 CY20071100200T CY071100200T CY1106019T1 CY 1106019 T1 CY1106019 T1 CY 1106019T1 CY 20071100200 T CY20071100200 T CY 20071100200T CY 071100200 T CY071100200 T CY 071100200T CY 1106019 T1 CY1106019 T1 CY 1106019T1
Authority
CY
Cyprus
Prior art keywords
therapeutic treatment
estrogen replacement
replacement therapeutic
estradiol
estrogen
Prior art date
Application number
CY20071100200T
Other languages
Greek (el)
English (en)
Inventor
Robert Casper
Gideon Kopernik
Zeev Shoham
Original Assignee
Robert Casper
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert Casper filed Critical Robert Casper
Publication of CY1106019T1 publication Critical patent/CY1106019T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CY20071100200T 2002-08-28 2007-02-14 Θepαπευτικη αγωγη αντικαταστασεως των οιστρογονων CY1106019T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40633102P 2002-08-28 2002-08-28
PCT/CA2003/001325 WO2004019954A1 (en) 2002-08-28 2003-08-28 Estrogen replacement regimen

Publications (1)

Publication Number Publication Date
CY1106019T1 true CY1106019T1 (el) 2011-04-06

Family

ID=31978284

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100200T CY1106019T1 (el) 2002-08-28 2007-02-14 Θepαπευτικη αγωγη αντικαταστασεως των οιστρογονων

Country Status (25)

Country Link
US (1) US8946198B2 (cg-RX-API-DMAC7.html)
EP (1) EP1539184B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005538150A (cg-RX-API-DMAC7.html)
KR (1) KR20050059092A (cg-RX-API-DMAC7.html)
CN (1) CN1678324A (cg-RX-API-DMAC7.html)
AT (1) ATE345804T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003264203A1 (cg-RX-API-DMAC7.html)
BR (1) BR0313921A (cg-RX-API-DMAC7.html)
CA (1) CA2495330A1 (cg-RX-API-DMAC7.html)
CY (1) CY1106019T1 (cg-RX-API-DMAC7.html)
DE (1) DE60309895T2 (cg-RX-API-DMAC7.html)
DK (1) DK1539184T3 (cg-RX-API-DMAC7.html)
ES (1) ES2277139T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20050291A2 (cg-RX-API-DMAC7.html)
IL (1) IL166585A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA05002294A (cg-RX-API-DMAC7.html)
NO (1) NO20051545L (cg-RX-API-DMAC7.html)
NZ (1) NZ538342A (cg-RX-API-DMAC7.html)
PL (1) PL374762A1 (cg-RX-API-DMAC7.html)
PT (1) PT1539184E (cg-RX-API-DMAC7.html)
RS (1) RS20050184A (cg-RX-API-DMAC7.html)
RU (1) RU2340345C2 (cg-RX-API-DMAC7.html)
UA (1) UA82851C2 (cg-RX-API-DMAC7.html)
WO (1) WO2004019954A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200501274B (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
DE102009007771B4 (de) 2009-02-05 2012-02-16 Bayer Schering Pharma Aktiengesellschaft Bukkales Applikationssystem, 17α-Estradiol enthaltend
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
MX2016011801A (es) * 2014-03-12 2017-07-14 Warner Chilcott Co Llc Crema de estradiol de dosis baja.
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
MA44206B1 (fr) 2015-06-18 2021-04-30 Estetra Sprl Comprimé orodispersible comprenant estetrol
EP3701944B1 (en) 2015-06-18 2021-12-08 Estetra SRL Orodispersible dosage unit containing an estetrol component
CU24523B1 (es) 2015-06-18 2021-06-08 Estetra Sprl Unidad de dosificación orodispersable que contiene un componente estetrol
JP2018522854A (ja) 2015-06-22 2018-08-16 リポカイン インコーポレーテッド 17−ヒドロキシプロゲステロンエステル含有経口組成物及び関連方法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
EP3781171B1 (en) 2018-04-19 2022-02-09 Estetra SRL Compounds and their uses for alleviating menopause-associated symptoms
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
DE19975054I2 (de) 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
US5256421A (en) 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
FI101601B (fi) * 1987-09-24 1998-07-31 Jencap Res Ltd Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmist een valmistusmenetelmässä
US5108995A (en) 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5422119A (en) 1987-09-24 1995-06-06 Jencap Research Ltd. Transdermal hormone replacement therapy
US5382873A (en) 1991-12-04 1995-01-17 U.S. Philips Corporation High-pressure discharge lamp with incandescing metal droplets
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
PL181582B1 (pl) * 1995-06-07 2001-08-31 Ortho Mcneil Pharm Inc Plaster na skóre do zapobiegania owulacji u kobiety oraz plaster na skóre do przeprowadzania hormonalnej terapii substytucyjnej PL PL PL PL PL PL PL PL
US6506390B2 (en) * 1996-06-25 2003-01-14 Akzo Nobel Progestogen-anti-progestogen regimens
CA2267743C (en) * 1999-03-30 2011-07-26 Robert F. Casper Low dose estrogen interrupted hormone replacement therapy
US6653298B2 (en) * 2000-01-14 2003-11-25 Sterix Limited Composition
DE10100911A1 (de) * 2001-01-11 2002-08-01 Schering Ag Verfahren zur Hormonersatztherapie und dessen Darreichungsform

Also Published As

Publication number Publication date
HRP20050291A2 (en) 2005-10-31
BR0313921A (pt) 2005-07-19
PT1539184E (pt) 2007-02-28
ES2277139T3 (es) 2007-07-01
CN1678324A (zh) 2005-10-05
ATE345804T1 (de) 2006-12-15
DK1539184T3 (da) 2007-03-19
ZA200501274B (en) 2006-08-30
EP1539184A1 (en) 2005-06-15
UA82851C2 (en) 2008-05-26
DE60309895D1 (de) 2007-01-04
RS20050184A (sr) 2007-11-15
PL374762A1 (en) 2005-10-31
US8946198B2 (en) 2015-02-03
CA2495330A1 (en) 2004-03-11
EP1539184B1 (en) 2006-11-22
MXPA05002294A (es) 2005-09-12
WO2004019954A1 (en) 2004-03-11
IL166585A0 (en) 2006-01-15
NO20051545L (no) 2005-03-23
RU2005108977A (ru) 2005-10-10
US20060089337A1 (en) 2006-04-27
JP2005538150A (ja) 2005-12-15
RU2340345C2 (ru) 2008-12-10
KR20050059092A (ko) 2005-06-17
AU2003264203A1 (en) 2004-03-19
NZ538342A (en) 2007-08-31
DE60309895T2 (de) 2007-10-18

Similar Documents

Publication Publication Date Title
ATE345804T1 (de) Estrogenersatztherapie
CY1106457T1 (el) Φαρμακευτικη συνθεση για τη χρηση σε θepαπεια ορμονικης υποκαταστασεως
SA521430055B1 (ar) عمليات ومركبات لتحضير مدهور مستقبل إستروجين انتقائي
CY1109088T1 (el) Μεθοδος για την παρασκευη υποκατεστημενων ενωσεων 3-αρυλο-βουτυλ-αμινης
CY1121922T1 (el) Θεραπευτικοι παραγοντες για τη μειωση των επιπεδων παραθορμονης
BR0309355A (pt) 2-(2,6-diclorofenil)-diarilimidazóis
CY1107074T1 (el) Συνθεση εναντιομερων 4-αμινο-θαλιδομιδης
DK1255537T3 (da) Farnesylproteintransferasehæmmere til behandling af brystcancer
TW200528117A (en) Methods and reagents for the treatment of proliferative diseases
IL169881A0 (en) Adhesive patches for the transdermal delivery of granisetron
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
CY1105646T1 (el) Συνεχης ορμονικη θεραπεια αντικαταστασης με ανασταλτικο της σουλφατασης προγεσταγονο
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
CY1113959T1 (el) Χρηση λιποσωματων pvp-ιωδιου για θεραπεια ακμης
MX9601368A (es) Metodo de tratamiento de la reestenosis por terapia genica.
UY26133A1 (es) Derivado sustituido de pirazol.
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
DK1441724T3 (da) Fremgangsmåde til forögelse af endogene testosteronniveauer
MXPA05008347A (es) Composicion que comprende una combinacion de un inhibidor de aromatasa, una progestina y un estrogeno y su uso para el tratamiento de endometriosis.
EA200702092A1 (ru) Липосомная композиция для индукции иммунитета
CY1110850T1 (el) Μεθοδος για την ταυτοποιηση ενωσεων με σκοπο την θεραπεια διαδικασιων γηρανσης του καρδιαγγειακου συστηματος
BR112021016923A2 (pt) Métodos para tratar um paciente com câncer hematológico, métodos para tratar um paciente com mm recidivante ou refratário, métodos para tratar um paciente tendo um lnh recidivante ou refratário e kits
CY1115587T1 (el) Μεθοδος και συνθεση για την θεραπεια παθησης με την μεσολαβηση ενος ληπτη σεροτονινης (sεrοτονιν)
MXPA05013975A (es) Tratamiento de enfermedades asociadas con amiloide y epileptogenesis.
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico